# C_2010005EN.01002301.xml

| 9.1.2010 | EN | Official Journal of the European Union | C 5/23 |
| --- | --- | --- | --- |

9.1.2010

EN

Official Journal of the European Union

C 5/23

---

Prior notification of a concentration

(Case COMP/M.5736 — TPG/IMS Health)

(Text with EEA relevance)

2010/C 5/06

| 1. | On 23 December 2009, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the private equity funds, TPG Partners V, L.P. (‘TPG V’) and TPG Partners VI, L.P. (‘TPG VI’), both belonging to the TPG group (‘TPG’, USA), acquire within the meaning of Article 3(1)(b) of the Regulation (EC) No 139/2004 control of the whole of the undertaking IMS Health Incorporated (‘IMS Health’, USA) by way of purchase of shares. |
| --- | --- |

1.

On 23 December 2009, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the private equity funds, TPG Partners V, L.P. (‘TPG V’) and TPG Partners VI, L.P. (‘TPG VI’), both belonging to the TPG group (‘TPG’, USA), acquire within the meaning of Article 3(1)(b) of the Regulation (EC) No 139/2004 control of the whole of the undertaking IMS Health Incorporated (‘IMS Health’, USA) by way of purchase of shares.

1

| 2. | The business activities of the undertakings concerned are:






  — | for TPG: private investment, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for TPG: private investment,

| — | for IMS Health: market research information and consulting services relating to the healthcare and pharmaceutical industries. |
| --- | --- |

—

for IMS Health: market research information and consulting services relating to the healthcare and pharmaceutical industries.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301 or 22967244) or by post, under reference number COMP/M.5736 — TPG/IMS Health, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301 or 22967244) or by post, under reference number COMP/M.5736 — TPG/IMS Health, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

---